TLRY remains a Hold, despite the double digits international growth prospects and the potential synergy from its vertically ...

Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S.

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.

TLRY posts a standout international quarter as cannabis revenues jump 36% year over year, driving supply shifts and broader ...

SweetWater Brewing Company ("SweetWater Brewing" or "SweetWater"), the leading craft beer brand in the Southeast by Tilray ...

Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare ...

Tilray Medical, a division of Tilray Brands, recently rebranded its Italian unit as Tilray Medical Italia and expanded its EU-GMP certified medical cannabis portfolio, including multiple flower and ...

Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading higher after the company reported better-than-expected second quarter financial results.

The company's international cannabis sales soared by 36%, and it cut its losses in half.

Analysts expect Tilray to report a loss of 20 cents per share and quarterly revenue of $210.95 million. The company is also being watched by investors for its new subsidiary, Tilray Medical USA, which ...

The average one-year price target for Tilray Brands (NasdaqGS:TLRY) has been revised to $13.78 / share. This is a decrease of 19.93% from the prior estimate of $17.20 dated December 18, 2025. The ...